{"transactions":[{"id":3172341,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":149714,"kind":"person","name":"DHILLON AVTAR S","position":1,"cik":"0001260933","reported_name":"DHILLON AVTAR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-21T20:00:22.000Z","date":"2020-04-17","kind":"grant","acquired":true,"shares":12500,"price":1.55,"value":19375.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Equity award for board services pursuant to the OncoSec Medical Incorporated 2011 Stock Incentive Plan. The award fully vested on the grant date."}],"balance_after":62052,"source":{"system":"sec-edgar","filing":"0001493152-20-006875","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315220006875/ownership.xml","form_type":"4"}},{"id":3548653,"issuer":{"id":6807,"kind":"organization","name":"RANGE IMPACT, INC."},"owners":[{"id":149714,"kind":"person","name":"DHILLON AVTAR S","position":1,"cik":"0001260933","reported_name":"DHILLON AVTAR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-25T20:30:27.000Z","date":"2016-07-15","kind":"grant","acquired":true,"shares":925585,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Form 4 filed on August 17, 2016 listed 925,585 RSU's as vesting on March 1, 2017 and March 1, 2018. This was reported incorrectly. The\nshares awarded were not RSU's, they were restricted common stock. The vesting of the restricted common stock was initially granted with the\nfollowing vesting schedule: 462,793 of the shares shall vest on March 1, 2017 and 462,792 of the shares shall vest on March 1, 2018. That\nrestricted common stock award was amended and restated with the following vesting schedule: 462,793 of the shares shall vest on January 1,\n2018 and 462,792 of the shares shall vest on March 1, 2018. Further, the restricted common stock award was amended and restated a second\ntime with the following vesting schedule: 925,585 of the shares shall vest on January 1, 2019."},{"field":"shares","element":"transactionShares","label":"F1","text":"The Form 4 filed on August 17, 2016 listed 925,585 RSU's as vesting on March 1, 2017 and March 1, 2018. This was reported incorrectly. The\nshares awarded were not RSU's, they were restricted common stock. The vesting of the restricted common stock was initially granted with the\nfollowing vesting schedule: 462,793 of the shares shall vest on March 1, 2017 and 462,792 of the shares shall vest on March 1, 2018. That\nrestricted common stock award was amended and restated with the following vesting schedule: 462,793 of the shares shall vest on January 1,\n2018 and 462,792 of the shares shall vest on March 1, 2018. Further, the restricted common stock award was amended and restated a second\ntime with the following vesting schedule: 925,585 of the shares shall vest on January 1, 2019."}],"balance_after":1015585,"source":{"system":"sec-edgar","filing":"0001493152-19-005937","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438943/000149315219005937/ownership.xml","form_type":"4/A","original_submission_date":"2016-08-17"}},{"id":3703864,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":149714,"kind":"person","name":"DHILLON AVTAR S","position":1,"cik":"0001260933","reported_name":"DHILLON AVTAR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-04T21:01:53.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This is a long-term equity incentive award of stock options which will vest quarterly over the next three years. The first vesting will occur on 1/31/2019, and the award will be fully vested on 10/31/2021 pursuant to the OncoSec Medical Incorporated 2011 Stock Incentive Plan."}],"balance_after":50000,"derivative":{"exercise_price":0.655,"exercise_date":"2019-01-31","expiration_date":"2029-01-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-19-000207","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315219000207/ownership.xml","form_type":"4"}},{"id":3741969,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":149714,"kind":"person","name":"DHILLON AVTAR S","position":1,"cik":"0001260933","reported_name":"DHILLON AVTAR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2018-12-06T22:17:19.000Z","date":"2018-12-06","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014."},{"field":"shares","element":"transactionShares","label":"F1","text":"Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vested and became exercisable on various dates between December 9, 2008 and December 9, 2011."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014."}],"balance_after":0,"derivative":{"exercise_price":2,"exercise_date":"2008-12-09","expiration_date":"2018-12-09","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001055726-18-000049","document":"wf-form4_154413462054861.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572618000049/wf-form4_154413462054861.xml","form_type":"4"}},{"id":3741968,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":149714,"kind":"person","name":"DHILLON AVTAR S","position":1,"cik":"0001260933","reported_name":"DHILLON AVTAR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-06T22:17:19.000Z","date":"2018-12-06","kind":"exercise","acquired":true,"shares":25000,"price":2,"value":50000.0,"ownership":{"direct":true},"balance_after":106002,"source":{"system":"sec-edgar","filing":"0001055726-18-000049","document":"wf-form4_154413462054861.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572618000049/wf-form4_154413462054861.xml","form_type":"4"}},{"id":3791797,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":149714,"kind":"person","name":"DHILLON AVTAR S","position":1,"cik":"0001260933","reported_name":"DHILLON AVTAR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2018-10-12T13:05:53.000Z","date":"2018-10-10","kind":"grant","acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in equal monthly installments over a one-year period commencing on the date of grant."}],"balance_after":1000000,"derivative":{"exercise_price":0.305,"expiration_date":"2028-10-10","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001209191-18-054871","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260933/000120919118054871/doc4.xml","form_type":"4"}},{"id":3863545,"issuer":{"id":109849,"kind":"organization","name":"Arch Therapeutics, Inc.","symbol":"ARTH"},"owners":[{"id":149714,"kind":"person","name":"DHILLON AVTAR S","position":1,"cik":"0001260933","reported_name":"DHILLON AVTAR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-07-20T13:13:33.000Z","date":"2018-07-19","kind":"grant","acquired":true,"shares":220000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Amount or Number of shares of Common Stock listed in Column 7 of the reporting person's original Form 4 was inadvertently listed as \"200,000\"."},{"field":"security","element":"securityTitle","label":"F2","text":"The grants reported on this Statement of Changes in Beneficial Ownership on Form 4 were made in connection with that certain letter agreement dated July 19, 2018 by and between the reporting person and Arch Therapeutics, Inc. (the \"Company\") pursuant to which the reporting person was engaged as an advisor to the Company. The reporting person resigned from his position as a director of the Company effective as of 4:00 PM Eastern Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Of the Shares subject to this Grant, 1/12th shall on each of the next twelve (12) monthly anniversaries of the vesting commencement date."}],"balance_after":220000,"derivative":{"exercise_price":0.425,"expiration_date":"2028-07-18","underlying":"Common Stock","underlying_shares":220000},"source":{"system":"sec-edgar","filing":"0001144204-18-039106","document":"tv498917_4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260933/000114420418039106/tv498917_4a.xml","form_type":"4/A","original_submission_date":"2018-07-20"}},{"id":3863544,"issuer":{"id":109849,"kind":"organization","name":"Arch Therapeutics, Inc.","symbol":"ARTH"},"owners":[{"id":149714,"kind":"person","name":"DHILLON AVTAR S","position":1,"cik":"0001260933","reported_name":"DHILLON AVTAR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-07-20T12:00:31.000Z","date":"2018-07-19","kind":"grant","acquired":true,"shares":220000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The grants reported on this Statement of Changes in Beneficial Ownership on Form 4 were made in connection with that certain letter agreement dated July 19, 2018 by and between the reporting person and Arch Therapeutics, Inc. (the \"Company\") pursuant to which the reporting person was engaged as an advisor to the Company. The reporting person resigned from his position as a director of the Company effective as of 4:00 PM Eastern Time, July 19, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Of the Shares subject to this Grant, 1/12th shall on each of the next twelve (12) monthly anniversaries of the vesting commencement date."}],"balance_after":220000,"derivative":{"exercise_price":0.425,"expiration_date":"2028-07-18","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001144204-18-039091","document":"tv498881_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1260933/000114420418039091/tv498881_4.xml","form_type":"4"}},{"id":3863543,"issuer":{"id":109849,"kind":"organization","name":"Arch Therapeutics, Inc.","symbol":"ARTH"},"owners":[{"id":149714,"kind":"person","name":"DHILLON AVTAR S","position":1,"cik":"0001260933","reported_name":"DHILLON AVTAR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-20T12:00:31.000Z","date":"2018-07-19","kind":"grant","acquired":true,"shares":220000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The grants reported on this Statement of Changes in Beneficial Ownership on Form 4 were made in connection with that certain letter agreement dated July 19, 2018 by and between the reporting person and Arch Therapeutics, Inc. (the \"Company\") pursuant to which the reporting person was engaged as an advisor to the Company. The reporting person resigned from his position as a director of the Company effective as of 4:00 PM Eastern Time, July 19, 2018."},{"field":"security","element":"securityTitle","label":"F2","text":"Of the Shares subject to this grant, all are issued pursuant to the 2013 Stock Incentive Plan (the \"Plan\") and 100% shall fully vest on the second anniversary of the date of grant. In addition, in the event of a Change of Control (as such term is defined in the Plan) 100% of grant will immediately vest."}],"balance_after":8517373,"source":{"system":"sec-edgar","filing":"0001144204-18-039091","document":"tv498881_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260933/000114420418039091/tv498881_4.xml","form_type":"4"}},{"id":3871734,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":149714,"kind":"person","name":"DHILLON AVTAR S","position":1,"cik":"0001260933","reported_name":"DHILLON AVTAR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-07-06T16:40:19.000Z","date":"2018-06-15","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit."}],"balance_after":0,"derivative":{"exercise_date":"2019-03-04","expiration_date":"2019-03-04","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-18-009767","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009767/ownership.xml","form_type":"4"}},{"id":3871733,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":149714,"kind":"person","name":"DHILLON AVTAR S","position":1,"cik":"0001260933","reported_name":"DHILLON AVTAR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-06T16:40:19.000Z","date":"2018-07-05","kind":"sale","acquired":false,"shares":3100,"price":1.312,"value":4067.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Sale to cover taxes on restricted stock unit vesting."}],"balance_after":143427,"source":{"system":"sec-edgar","filing":"0001493152-18-009767","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009767/ownership.xml","form_type":"4"}},{"id":3871732,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":149714,"kind":"person","name":"DHILLON AVTAR S","position":1,"cik":"0001260933","reported_name":"DHILLON AVTAR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-06T16:40:19.000Z","date":"2018-06-29","kind":"sale","acquired":false,"shares":1066,"price":1.38,"value":1471.08,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Sale to cover taxes on restricted stock unit vesting."}],"balance_after":146527,"source":{"system":"sec-edgar","filing":"0001493152-18-009767","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009767/ownership.xml","form_type":"4"}},{"id":3871731,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":149714,"kind":"person","name":"DHILLON AVTAR S","position":1,"cik":"0001260933","reported_name":"DHILLON AVTAR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-06T16:40:19.000Z","date":"2018-06-28","kind":"sale","acquired":false,"shares":1556,"price":1.401,"value":2179.956,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Sale to cover taxes on restricted stock unit vesting."}],"balance_after":147593,"source":{"system":"sec-edgar","filing":"0001493152-18-009767","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009767/ownership.xml","form_type":"4"}},{"id":3871730,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":149714,"kind":"person","name":"DHILLON AVTAR S","position":1,"cik":"0001260933","reported_name":"DHILLON AVTAR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-06T16:40:19.000Z","date":"2018-06-27","kind":"sale","acquired":false,"shares":3451,"price":1.374,"value":4741.674,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Sale to cover taxes on restricted stock unit vesting."}],"balance_after":149149,"source":{"system":"sec-edgar","filing":"0001493152-18-009767","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009767/ownership.xml","form_type":"4"}},{"id":3871729,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":149714,"kind":"person","name":"DHILLON AVTAR S","position":1,"cik":"0001260933","reported_name":"DHILLON AVTAR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-06T16:40:19.000Z","date":"2018-06-26","kind":"sale","acquired":false,"shares":4703,"price":1.398,"value":6574.794,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Sale to cover taxes on restricted stock unit vesting."}],"balance_after":152600,"source":{"system":"sec-edgar","filing":"0001493152-18-009767","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009767/ownership.xml","form_type":"4"}},{"id":3871728,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":149714,"kind":"person","name":"DHILLON AVTAR S","position":1,"cik":"0001260933","reported_name":"DHILLON AVTAR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-06T16:40:19.000Z","date":"2018-06-25","kind":"sale","acquired":false,"shares":202,"price":1.405,"value":283.81,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Sale to cover taxes on restricted stock unit vesting."}],"balance_after":157303,"source":{"system":"sec-edgar","filing":"0001493152-18-009767","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009767/ownership.xml","form_type":"4"}},{"id":3871727,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":149714,"kind":"person","name":"DHILLON AVTAR S","position":1,"cik":"0001260933","reported_name":"DHILLON AVTAR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-06T16:40:19.000Z","date":"2018-06-22","kind":"sale","acquired":false,"shares":2956,"price":1.418,"value":4191.608,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Sale to cover taxes on restricted stock unit vesting."}],"balance_after":157505,"source":{"system":"sec-edgar","filing":"0001493152-18-009767","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009767/ownership.xml","form_type":"4"}},{"id":3871726,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":149714,"kind":"person","name":"DHILLON AVTAR S","position":1,"cik":"0001260933","reported_name":"DHILLON AVTAR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-06T16:40:19.000Z","date":"2018-06-21","kind":"sale","acquired":false,"shares":2178,"price":1.401,"value":3051.378,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Sale to cover taxes on restricted stock unit vesting."}],"balance_after":160461,"source":{"system":"sec-edgar","filing":"0001493152-18-009767","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009767/ownership.xml","form_type":"4"}},{"id":3871725,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":149714,"kind":"person","name":"DHILLON AVTAR S","position":1,"cik":"0001260933","reported_name":"DHILLON AVTAR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-06T16:40:19.000Z","date":"2018-06-20","kind":"sale","acquired":false,"shares":10973,"price":1.422,"value":15603.606,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Sale to cover taxes on restricted stock unit vesting."}],"balance_after":162639,"source":{"system":"sec-edgar","filing":"0001493152-18-009767","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009767/ownership.xml","form_type":"4"}},{"id":3871724,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":149714,"kind":"person","name":"DHILLON AVTAR S","position":1,"cik":"0001260933","reported_name":"DHILLON AVTAR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-06T16:40:19.000Z","date":"2018-06-19","kind":"sale","acquired":false,"shares":1838,"price":1.364,"value":2507.032,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Sale to cover taxes on restricted stock unit vesting."}],"balance_after":173612,"source":{"system":"sec-edgar","filing":"0001493152-18-009767","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009767/ownership.xml","form_type":"4"}},{"id":3871723,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":149714,"kind":"person","name":"DHILLON AVTAR S","position":1,"cik":"0001260933","reported_name":"DHILLON AVTAR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-06T16:40:19.000Z","date":"2018-06-18","kind":"sale","acquired":false,"shares":5552,"price":1.386,"value":7695.072,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Sale to cover taxes on restricted stock unit vesting."}],"balance_after":175450,"source":{"system":"sec-edgar","filing":"0001493152-18-009767","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009767/ownership.xml","form_type":"4"}},{"id":3871722,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":149714,"kind":"person","name":"DHILLON AVTAR S","position":1,"cik":"0001260933","reported_name":"DHILLON AVTAR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-06T16:40:19.000Z","date":"2018-06-15","kind":"exercise","acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit."}],"balance_after":181002,"source":{"system":"sec-edgar","filing":"0001493152-18-009767","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009767/ownership.xml","form_type":"4"}},{"id":3935307,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":149714,"kind":"person","name":"DHILLON AVTAR S","position":1,"cik":"0001260933","reported_name":"DHILLON AVTAR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2018-05-14T22:03:33.000Z","date":"2018-05-12","kind":"exercise","acquired":false,"shares":7669,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 12, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 12, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 12, 2018."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7669},"source":{"system":"sec-edgar","filing":"0001055726-18-000028","document":"wf-form4_152633540004579.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572618000028/wf-form4_152633540004579.xml","form_type":"4"}},{"id":3935306,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":149714,"kind":"person","name":"DHILLON AVTAR S","position":1,"cik":"0001260933","reported_name":"DHILLON AVTAR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2018-05-14T22:03:33.000Z","date":"2018-05-11","kind":"grant","acquired":true,"shares":8170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 11, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 11, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 11, 2019."}],"balance_after":8170,"derivative":{"underlying":"Common Stock","underlying_shares":8170},"source":{"system":"sec-edgar","filing":"0001055726-18-000028","document":"wf-form4_152633540004579.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572618000028/wf-form4_152633540004579.xml","form_type":"4"}},{"id":3935305,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":149714,"kind":"person","name":"DHILLON AVTAR S","position":1,"cik":"0001260933","reported_name":"DHILLON AVTAR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Option","published_at":"2018-05-14T22:03:33.000Z","date":"2018-05-11","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to vest 100% on May 11, 2019."}],"balance_after":12500,"derivative":{"exercise_price":4.56,"expiration_date":"2028-05-11","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001055726-18-000028","document":"wf-form4_152633540004579.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572618000028/wf-form4_152633540004579.xml","form_type":"4"}},{"id":3935304,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":149714,"kind":"person","name":"DHILLON AVTAR S","position":1,"cik":"0001260933","reported_name":"DHILLON AVTAR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-14T22:03:33.000Z","date":"2018-05-12","kind":"exercise","acquired":true,"shares":7669,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 12, 2018."}],"balance_after":81002,"source":{"system":"sec-edgar","filing":"0001055726-18-000028","document":"wf-form4_152633540004579.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572618000028/wf-form4_152633540004579.xml","form_type":"4"}},{"id":4068475,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":149714,"kind":"person","name":"DHILLON AVTAR S","position":1,"cik":"0001260933","reported_name":"DHILLON AVTAR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2018-02-09T17:34:30.000Z","date":"2018-02-08","kind":"grant","acquired":true,"shares":350000,"price":1.64,"value":574000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting in 12 equal monthly increments, with the first 1/12th vesting on the first monthly anniversary of the Grant Date pursuant to the OncoSec Medical Incorporated 2011 Stock Incentive Plan."}],"balance_after":647916,"derivative":{"exercise_price":1.64,"exercise_date":"2018-03-02","expiration_date":"2028-02-08","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001493152-18-001770","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218001770/form4.xml","form_type":"4"}},{"id":4321248,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":149714,"kind":"person","name":"DHILLON AVTAR S","position":1,"cik":"0001260933","reported_name":"DHILLON AVTAR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2017-05-15T21:05:05.000Z","date":"2017-05-13","kind":"exercise","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 13, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 13, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 13, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 13, 2017."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001055726-17-000027","document":"wf-form4_149488228594511.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572617000027/wf-form4_149488228594511.xml","form_type":"4"}},{"id":4321247,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":149714,"kind":"person","name":"DHILLON AVTAR S","position":1,"cik":"0001260933","reported_name":"DHILLON AVTAR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2017-05-15T21:05:05.000Z","date":"2017-05-12","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options to vest 100% on May 12, 2018."}],"balance_after":12500,"derivative":{"exercise_price":7.14,"exercise_date":"2018-05-12","expiration_date":"2027-05-12","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001055726-17-000027","document":"wf-form4_149488228594511.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572617000027/wf-form4_149488228594511.xml","form_type":"4"}},{"id":4321246,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":149714,"kind":"person","name":"DHILLON AVTAR S","position":1,"cik":"0001260933","reported_name":"DHILLON AVTAR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2017-05-15T21:05:05.000Z","date":"2017-05-12","kind":"grant","acquired":true,"shares":7669,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 12, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 12, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 12, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 12, 2018."}],"balance_after":7669,"derivative":{"underlying":"Common Stock","underlying_shares":7669},"source":{"system":"sec-edgar","filing":"0001055726-17-000027","document":"wf-form4_149488228594511.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572617000027/wf-form4_149488228594511.xml","form_type":"4"}},{"id":4321245,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":149714,"kind":"person","name":"DHILLON AVTAR S","position":1,"cik":"0001260933","reported_name":"DHILLON AVTAR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-15T21:05:05.000Z","date":"2017-05-13","kind":"exercise","acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 13, 2017."}],"balance_after":73333,"source":{"system":"sec-edgar","filing":"0001055726-17-000027","document":"wf-form4_149488228594511.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572617000027/wf-form4_149488228594511.xml","form_type":"4"}},{"id":4366809,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":149714,"kind":"person","name":"DHILLON AVTAR S","position":1,"cik":"0001260933","reported_name":"DHILLON AVTAR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2017-03-31T21:31:35.000Z","date":"2017-03-29","kind":"grant","acquired":true,"shares":20000,"price":1.34,"value":26800.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting in 12 equal monthly increments, with the first 1/12th vesting on the first monthly anniversary of the Grant Date pursuant to the OncoSec Medical Incorporated 2011 Stock Incentive Plan."}],"balance_after":297916,"derivative":{"exercise_price":1.34,"exercise_date":"2017-04-29","expiration_date":"2027-03-29","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001493152-17-003325","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315217003325/form4.xml","form_type":"4"}},{"id":4466134,"issuer":{"id":109849,"kind":"organization","name":"Arch Therapeutics, Inc.","symbol":"ARTH"},"owners":[{"id":149714,"kind":"person","name":"DHILLON AVTAR S","position":1,"cik":"0001260933","reported_name":"DHILLON AVTAR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-02-06T11:28:15.000Z","date":"2017-02-03","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Of the Shares subject to this Grant, 1/12th shall on each of the next twelve (12) monthly anniversaries of the vesting commencement date."}],"balance_after":400000,"derivative":{"exercise_price":0.65,"expiration_date":"2027-02-02","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001144204-17-006092","document":"v458449_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1260933/000114420417006092/v458449_4.xml","form_type":"4"}},{"id":4466133,"issuer":{"id":109849,"kind":"organization","name":"Arch Therapeutics, Inc.","symbol":"ARTH"},"owners":[{"id":149714,"kind":"person","name":"DHILLON AVTAR S","position":1,"cik":"0001260933","reported_name":"DHILLON AVTAR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-06T11:28:15.000Z","date":"2017-02-03","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Of the Shares subject to this grant, all are issued pursuant to the 2013 Stock Incentive Plan (the \"Plan\") and 100% shall fully vest on the second anniversary of the date of grant. In addition, in the event of a Change of Control (as such term is defined in the Plan) 100% of grant will immediately vest."}],"balance_after":8297373,"source":{"system":"sec-edgar","filing":"0001144204-17-006092","document":"v458449_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260933/000114420417006092/v458449_4.xml","form_type":"4"}},{"id":4518796,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":149714,"kind":"person","name":"DHILLON AVTAR S","position":1,"cik":"0001260933","reported_name":"DHILLON AVTAR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-12-16T17:24:37.000Z","date":"2016-12-14","kind":"grant","acquired":true,"shares":265416,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 14, 2016, OncoSec Medical Incorporated cancelled, pursuant to its Stock Option Exchange Program, options previously granted to and held by the reporting person to purchase 5000 shares (previously granted on April 25, 2012) 5000 shares (previously granted on April 15, 2013), 12500 shares (previously granted on March 7, 2014), 12500 shares (previously granted on March 3, 2015), and 500000 shares (previously granted on August 21, 2015) of common stock. In exchange, and subject to the terms of the Stock Option Exchange Program, the reporting person received a replacement option for 265416 shares of common stock with an exercise price of $1.29 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The stock options granted on December 14, 2016 will vest on the following schedule: 25% on grant date; 1/12th of the remaining 75% vesting on each of the 12 subsequent monthly anniversaries of the grant date."}],"balance_after":265416,"derivative":{"exercise_price":1.29,"expiration_date":"2026-12-14","underlying":"Common Stock","underlying_shares":265416},"source":{"system":"sec-edgar","filing":"0001493152-16-015976","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315216015976/form4.xml","form_type":"4"}},{"id":4518795,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":149714,"kind":"person","name":"DHILLON AVTAR S","position":1,"cik":"0001260933","reported_name":"DHILLON AVTAR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-12-16T17:24:37.000Z","date":"2016-12-14","kind":"disposition_to_issuer","acquired":false,"shares":500000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 14, 2016, OncoSec Medical Incorporated cancelled, pursuant to its Stock Option Exchange Program, options previously granted to and held by the reporting person to purchase 5000 shares (previously granted on April 25, 2012) 5000 shares (previously granted on April 15, 2013), 12500 shares (previously granted on March 7, 2014), 12500 shares (previously granted on March 3, 2015), and 500000 shares (previously granted on August 21, 2015) of common stock. In exchange, and subject to the terms of the Stock Option Exchange Program, the reporting person received a replacement option for 265416 shares of common stock with an exercise price of $1.29 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These stock options were fully vested on August 21, 2016, the first anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":5.76,"expiration_date":"2025-08-21","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001493152-16-015976","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315216015976/form4.xml","form_type":"4"}},{"id":4518794,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":149714,"kind":"person","name":"DHILLON AVTAR S","position":1,"cik":"0001260933","reported_name":"DHILLON AVTAR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-12-16T17:24:37.000Z","date":"2016-12-14","kind":"disposition_to_issuer","acquired":false,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 14, 2016, OncoSec Medical Incorporated cancelled, pursuant to its Stock Option Exchange Program, options previously granted to and held by the reporting person to purchase 5000 shares (previously granted on April 25, 2012) 5000 shares (previously granted on April 15, 2013), 12500 shares (previously granted on March 7, 2014), 12500 shares (previously granted on March 3, 2015), and 500000 shares (previously granted on August 21, 2015) of common stock. In exchange, and subject to the terms of the Stock Option Exchange Program, the reporting person received a replacement option for 265416 shares of common stock with an exercise price of $1.29 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These stock options were fully vested on March 3, 2016, the first anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":7.6,"expiration_date":"2025-03-03","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001493152-16-015976","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315216015976/form4.xml","form_type":"4"}},{"id":4518793,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":149714,"kind":"person","name":"DHILLON AVTAR S","position":1,"cik":"0001260933","reported_name":"DHILLON AVTAR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-12-16T17:24:37.000Z","date":"2016-12-14","kind":"disposition_to_issuer","acquired":false,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 14, 2016, OncoSec Medical Incorporated cancelled, pursuant to its Stock Option Exchange Program, options previously granted to and held by the reporting person to purchase 5000 shares (previously granted on April 25, 2012) 5000 shares (previously granted on April 15, 2013), 12500 shares (previously granted on March 7, 2014), 12500 shares (previously granted on March 3, 2015), and 500000 shares (previously granted on August 21, 2015) of common stock. In exchange, and subject to the terms of the Stock Option Exchange Program, the reporting person received a replacement option for 265416 shares of common stock with an exercise price of $1.29 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These stock options were fully vested on March 7, 2015, the first anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":16.1,"expiration_date":"2024-03-07","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001493152-16-015976","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315216015976/form4.xml","form_type":"4"}},{"id":4518792,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":149714,"kind":"person","name":"DHILLON AVTAR S","position":1,"cik":"0001260933","reported_name":"DHILLON AVTAR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-12-16T17:24:37.000Z","date":"2016-12-14","kind":"disposition_to_issuer","acquired":false,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 14, 2016, OncoSec Medical Incorporated cancelled, pursuant to its Stock Option Exchange Program, options previously granted to and held by the reporting person to purchase 5000 shares (previously granted on April 25, 2012) 5000 shares (previously granted on April 15, 2013), 12500 shares (previously granted on March 7, 2014), 12500 shares (previously granted on March 3, 2015), and 500000 shares (previously granted on August 21, 2015) of common stock. In exchange, and subject to the terms of the Stock Option Exchange Program, the reporting person received a replacement option for 265416 shares of common stock with an exercise price of $1.29 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These stock options were fully vested on April 15, 2014, the first anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":5,"expiration_date":"2023-04-15","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001493152-16-015976","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315216015976/form4.xml","form_type":"4"}},{"id":4518791,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":149714,"kind":"person","name":"DHILLON AVTAR S","position":1,"cik":"0001260933","reported_name":"DHILLON AVTAR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-12-16T17:24:37.000Z","date":"2016-12-14","kind":"disposition_to_issuer","acquired":false,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 14, 2016, OncoSec Medical Incorporated cancelled, pursuant to its Stock Option Exchange Program, options previously granted to and held by the reporting person to purchase 5000 shares (previously granted on April 25, 2012) 5000 shares (previously granted on April 15, 2013), 12500 shares (previously granted on March 7, 2014), 12500 shares (previously granted on March 3, 2015), and 500000 shares (previously granted on August 21, 2015) of common stock. In exchange, and subject to the terms of the Stock Option Exchange Program, the reporting person received a replacement option for 265416 shares of common stock with an exercise price of $1.29 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options were fully vested on April 25, 2013, the first anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":4.2,"expiration_date":"2022-04-25","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001493152-16-015976","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315216015976/form4.xml","form_type":"4"}}]}